About Patrick Enright
Form D filings for CuraSen Therapeutics from 2019 to 2024 list Patrick Enright as director.
Patrick Enright first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Patrick Enright in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Patrick Enright works with at each company, as listed on that company's latest Form D.
CuraSen Therapeutics, Inc. · Form D, Sep 18, 2024
RH
Ron Hunt
Director
AF
Anthony Ford
President and Chief Executive Officer, director
BP
Benjamin Potter
Executive officer
LD
Loretta Tse, Ph.D.
Director
KG
Kathleen Glaub
Director
SD
Simon Tate, Ph.D.
Director